Abstract Individuals with hepatic lipase (HL) deficiency are often characterized by elevated levels of triglycerides and cholesterol and may be subject to premature atherosclerosis. Missense mutations in the HLgene have been identified in two affected families: substitutions of serine for phenylalanine at amino acid 267 and threonine for methionine at amino acid 383 (S267F and T383M, respectively). To confirm the role of S267F and T383M in HL deficiency, we introduced these mutations separately into human HL cDNA by site-directed mutagenesis, and the resulting constructs were independently expressed in COS cells. HL activity and mass were measured and compared with wild-type HL transfectants to determine the effect of these mutations on lipase activity and secretion. Although similar amounts of HL protein were detected intracellularly after transfection with the wild-type and mutant constructs, S267F and T383M HL activity levels were markedly decreased: in S267F, no HL activity was detected, and H epatic lipase (HL) is synthesized and secreted by hepatocytes and functions as an endothelium-bound enzyme within liver sinusoids.
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Abstract Individuals with hepatic lipase (HL) deficiency are often characterized by elevated levels of triglycerides and cholesterol and may be subject to premature atherosclerosis. Missense mutations in the HLgene have been identified in two affected families: substitutions of serine for phenylalanine at amino acid 267 and threonine for methionine at amino acid 383 (S267F and T383M, respectively). To confirm the role of S267F and T383M in HL deficiency, we introduced these mutations separately into human HL cDNA by site-directed mutagenesis, and the resulting constructs were independently expressed in COS cells. HL activity and mass were measured and compared with wild-type HL transfectants to determine the effect of these mutations on lipase activity and secretion. Although similar amounts of HL protein were detected intracellularly after transfection with the wild-type and mutant constructs, S267F and T383M HL activity levels were markedly decreased: in S267F, no HL activity was detected, and H epatic lipase (HL) is synthesized and secreted by hepatocytes and functions as an endothelium-bound enzyme within liver sinusoids. 13 The primary function of HL is hydrolysis of core triglycerides and surface phospholipids of chylomicron remnants and high-density lipoproteins (HDL) and intermediate-density lipoproteins.
2 - 3 The enzyme has been proposed to augment the uptake of HDL cholesterol by liver (ie, reverse cholesterol transport) and to be involved in the conversion of HDL 2 to HDL3. 2 -3 HL is also thought to increase the hepatic clearance of chylomicron remnants, possibly by aiding in the exposure of crucial apolipoprotein E epitopes. 4 These functions are important components of the lipid transport system that ultimately determines levels of circulating cholesterol and triglyceride. Indeed, individuals with reduced HL activity in postheparin plasma generally exhibit elevated levels of triglyceride and cholesterol and may be subject to premature atherosclerosis. 5 " 7 Heritable HL deficiency has been identified in several families. 6 - 813 Hegele et al 1415 analyzed genomic DNA from two of these families to determine whether the cause of HL deficiency was due to mutations occurring within the structural gene. They identified several base changes, three of which resulted in amino acid substitutions: an A-»G change located in exon 5 (nucleotide activity levels in T383M were 38% of wild-type HL. Heparininduced secretion of the two HL mutants was also severely affected: no detectable activity could be measured in the media of S267F, although some inactive mass (12% of wild-type HL) was secreted; mutant T383M secreted 4% and 20% of wild-type activity and mass, respectively. These results indicate that the single amino acid substitution present in HL S267F is sufficient to render the enzyme completely nonfunctional; in contrast, the T383M mutant retains partial activity but is poorly secreted. Thus, these defects appear capable of accounting for the HL-deficient phenotypes exhibited by individuals carrying the T383M and S267F mutations. ; a C-»T change in exon 6 (nucleotide 873), causing a nonconservative serine->phenylalanine substitution at position 267 (S267F) 15 ; and a C-»T change in exon 8 (nucleotide 1221), causing a nonconservative methionine-* threonine substitution at amino acid position 383 (T383M). 14 Although all individuals displaying the T383M mutation also earned the N193S mutation, an individual homozygous for N193S but not carrying the T383M mutation exhibited normal levels of postheparin plasma HL activity. 15 Within the HL-deficient subjects examined, the S267F and T383M mutations were present only in the heterozygous state. Of these, there were either simple or compound heterozygotes, ie, individuals possessing one normal and one mutant allele (+/S267F or +/T383M) or both mutant alleles (S267F/T383M), respectively. Although the simple heterozygotes exhibited reduced levels of HL activity in postheparin plasma, the magnitude of the decrease varied between the two mutations: 3.88±1.93 and 7.18±3.77 U/mL for S267F and T383M heterozygotes, respectively, compared with 9.71±1.46 U/mL for normal subjects (mean±SEM).
1415
HL activity was not detected in postheparin plasma of compound heterozygotes carrying both mutant alleles.
This study establishes the relevance of the S267F and T383M mutations with regard to HL function by examining lipase activity and secretion in cultured cells expressing these mutant alleles. The mutations were introduced separately into human HL cDNA by sitedirected mutagenesis and each construct independently expressed in COS cells. Our results indicate that both S267F and T383M perturb enzyme activity and secretion in vitro, strongly suggesting that these mutations form the molecular basis for the reported familial HL deficiency. 14 - 15 Nevertheless, the severity of these mutations with regard to HL function appears to be quite different. Whereas the S267F mutation completely inactivates the enzyme, partial activity (38%) is detected in HL carrying the T383M mutation. The T383M HL protein, however, is poorly secreted.
Methods

Construction of Human Hepatic Lipase S267F and T383M
The S267F and T383M mutations were introduced into human HL cDNA using the polymerase chain reaction (PCR) 16 and the method of overlap extension. 17 PCR was performed using primers 267PrHL (5-CATCGACTICT-TGCTGCACG-3') and 383PrHL (5'-CCTTTCTTATCAl-GCTGGATGTGG-3'). Both primers contained C-+T substitutions (underlined) at nucleotide positions 873 and 1221 (codons 267 and 383, respectively). (Note: The nucleotide and amino acid substitutions in familial HL deficiency as defined by Hegele et al 14 - 15 are based on the human HL sequence originally reported by Martin et al 18 ; to preserve the continuity of reporting the HL mutations, we have retained this numbering system throughout.) These primers, along with primer PolAPrHL [5'-GTACGGATCCGGTACC(A) ir 3'], were used to amplify the 3'-end of HL (nucleotides 866 to 1553, S267F, and nucleotides 1210 to 1553, T383M); the reverse of primers 267PrHL and 383PrHL were used in conjuction with primer 5PrHL (5'-GTCTAGACCCGGGTGAAACGGA-3') to amplify the 5'-end of HL (nucleotides 1 to 883, S267F, and nucleotides 1 to 1232, T383M). The amplification products were gel purified and used as annealed templates in a PCR reaction using primers PolAPrHL and 5PrHL; this PCR step spliced together the two templates into an entire HL cDNA (nucleotides 1 to 1553). The spliced HL cDNAs were subcloned into the mammalian expression vector pCDM8, which contains a highefficiency cytomegalovirus promoter to drive transcription of the insert DNA, along with an SV40 origin of replication for high expression in COS cells."- 21 The final constructs were called HL-pCDM8, S267F-pCDM8, and T383M-pCDM8, and the complete coding regions were verified by dideoxy sequencing. 22 Transfection COS-7 cells (American Type Culture Collection) were grown in Dulbecco's modified Eagle medium (GIBCO) supplemented with 10% calf serum (DMEM-CS). For electroporation, 1 to 2x 10~7 cells were suspended in 0.8 mL of electroporation buffer (0.15 mol/L NaCl, 20 mmol/L/V-2-hydroxyethylpiperazine-W-2-ethanesulfonic acid, pH 7.4) containing 40 iig/mL of plasmid DNA (30 yug HL-pCDM8, S267F-pCDM8, or T383M-pCDM8 and 10 n% of a /5-galactosidase expression plasmid, pCHHO). After incubation on ice for 10 minutes, the cells were exposed to a single voltage pulse (035 kV, 960 iiF using the Bio-Rad Gene Pulser) and kept on ice for an additional 10 minutes before being plated in 75-cm 2 tissue culture flasks. Four hours after transfection the media were changed and cell cultures maintained in DMEM-CS until confluent.
Twelve hours before harvesting, the cultures received fresh DMEM-CS containing heparin (Sigma, 10 U/mL). Each experiment was terminated by collecting the media, washing the culture flasks twice with phosphate-buffered saline (0.15 mol/L NaCl, 10 mmol/L sodium phosphate, pH 7.2), and harvesting the cell monolayer by scraping. The cells were homogenized in 500 fjiL of extraction buffer (50 mmol/L NHtOH/HCl, pH 8.1, containing 0.125% Triton X-100) and centrifuged at 4°C for 5 minutes. Supernatants were stored at -70°C until analyzed.
Assays
Total lysate protein was determined by the method of Lowry et al. 23 0-Galactosidase activity was determined in 5-and 10-jtL aliquots of each cell lysate by standard methods. 24 HL activity assays were performed using lysolecithin-emulsified 3 H-labeled trioleoglycerol as substrate. 25 Assays were carried out in the presence of 1 mol/L NaCl to inhibit any endogenous salt-sensitive lipase activity. Cell lysates were diluted at least 100-fold to prevent inhibition by Triton X-100 and to ensure that activity was linear with respect to enzyme concentration. 26 The assays were always carried out in two serial concentrations to verify assay linearity. One milliunit of HL enzyme activity represents the release of 1 nmol of free fatty acid per minute.
Detection of Hepatic Lipase Mass
Cell media and lysates were immunoprecipitated using a cross-linked protein A/anti-hHL IgG immunomatrix, prepared as described. 27 - 28 Aliquots of media and lysates were denatured by adding sodium dodecyl sulfate (SDS; final concentration, 0.5%) and boiling for 2 minutes. Samples were then mixed with a concentrated lysis buffer to give a final concentration of 0.1 mol/L tris(hydroxymethyl)aminomethane (Tris) (pH 7.5), 0.15 mol/L NaCl, 1 mmol/L EDTA, 2% Triton X-100, 0.5% AMauroylsarcosine, 0.1% SDS, and the following protease inhibitors: 50 /xg/mL soybean trypsin inhibitor, 20 kallikrein units/mL aprotinin, 157 /xg/rnL benzamidine, 4 /xg/mL leupeptin, and 1 pig/mL pepstatin. The samples were incubated for 48 hours at 4°C with the immunomatrix. After centrifugation, pellets were washed twice with lysis buffer and once with 50 mmol/L sodium phosphate buffer, pH 5.9, containing 0.1% /V-lauroylsarcosine. The antigen was released from the immunocomplex by boiling for 2 minutes in sodium phosphate buffer (50 mmol/L, pH 5.9) containing 0.5% SDS and 20% glycerol. Endoglycosidase (endo) H digestion was performed, 28 -29 and the samples were subjected to SDSpolyacrylamide gel electrophoresis (PAGE) using 7% acrylamide in the separating gel. 28 After SDS-PAGE, the gels were blotted at 200 mA for 60 minutes onto polyvinylidene difluoride membranes. Blotted membranes were incubated overnight with blocking buffer using reagents supplied in the Protein Images Western Blotting detection kit (United States Biochemicals). After blocking, the membranes were incubated overnight at 4°C with 1 itg/mL biotinylated anti-hHL IgG. After washing three times for 5 minutes with TBS-T (0.1 mol/L Tris, pH 7.5, containing 0.15 mol/L NaCl and 0.1% Tween-20), the membranes were incubated with streptavidin-conjugated horseradish peroxidase (Bio-Rad) diluted 1:2500 in TBS-T for 30 minutes. The blots were washed three times with TBS containing 0.3% Tween-20, followed by three washes with TBS-T, and coated for 60 seconds with chemiluminescence solution (Amersham, ECL reagents). The membranes were exposed to Kodak X-Omat AR film for 10 to 35 seconds.
Statistics
Values are reported as mean±SD. Statistical significance was computed with a paired two-tailed t test using STATVIEW II software.
Results
To establish whether the S267F and T383M mutations perturb HL activity and expression, C-»T substitutions were introduced into the human HL cDNA at nucleotide positions 873 and 1221, respectively. The mutant and wild-type cDNAs were subcloned into the pCDM8 expression vector and transfected into mammalian (COS) cells. COS cells were chosen because they express little endogenous lipase activity and can be transfected at high efficiency with plasmids such as pCDM8. For internal control of differences in the efficiency of transfection, a /3-galactosidase expression plasmid was included with each transfected wild-type HL (wtHL), S267F, and T383M construct. The £-galactosidase activity levels from three separate experiments, measured in relative units per milligram of cell protein, were 0.83 + 0.061, 0.94±0.072, and 0.71±0.038 for wtHL, S267F, and T383M, respectively. Compared with the wtHL value, the /3-galactosidase activity levels of S267F and T383M were not significantly different (P>.05).
The Table shows the HL activity levels of COS cells transfected with the wild-type and mutant constructs. HL activity in the S267F transfectants was not detectable in either the cells or heparinized media. In contrast, the T383M cell lysates contained 38% of wtHL activity levels, significantly higher than the background levels present in untransfected COS cells. However, this level of activity was not secreted; instead, only 4% of wild-type activity was detected in the heparinized media of T383M. Secretion of HL activity by T383M transfectants was also decreased by at least 80% when heparin was not present in the media. As shown above, these results cannot be explained by differences in transfection efficiency.
The decreased lipase activity in the S267F and T383M mutants could result from either decreased enzyme specific activity or from low levels of enzyme expression due to factors such as increased HL degradation. To distinguish between these possibilities, we determined HL mass in cell lysates and media from each transfectant using a combination of immunoprecipitation and Western blotting techniques (Figs 1 and  2 ). Partially purified HL from human postheparin plasma was used for comparison (lanes 1 of Figs 1 3 and 6), T383M-pCDM8 (383, lanes 4 and 7) , and S267F-pCDM8 (267, lanes 5 and 8). At confluence, cells were harvested and lysed. HL was immunopreciprtated from the combined cell lysates of five separate dishes for each transfected construct representing total cellular proteins and HL activities of 9.9 mg (22 mU), 13.1 mg (11 mil), and 10.0 mg (0.5 mU) for wtHL, T383M, and S267F, respectively. The resulting HL immunoprecipitates were divided into two equal aliquots, and one aliquot was subjected to endoglycosidase (endo) H digestion for 12 hours (+endo H). After polyacrylamide gel electrcphoresis and transfer to polyvinylidene difluoride membranes, blots weredeveloped using biotinylated HLantibody, streptavidinhorseradish peroxidase, and appropriate chemiluminescence reagents as described in "Methods." For comparison, lane 1 contains partially purified HL from human postheparin plasma (hHL).
2). In addition, cells and media of COS cells transfected with pCDM8 containing no insert DNA were immunoprecipitated alongside wild-type and mutant transfectants to control for any nonspecific protein detection (lanes 2 of Figs 1 and 2 ). Fig 1 legend and "Methods." Twelve hours before harvesting, transfected cultures received fresh Dulbecco's modified Eagle medium supplemented with calf serum containing 10 U/mL heparin. Two milliliters of media from COS cells transfected with pCDM8 alone (no insert), hHL-pCDM8 (wt), T383M-pCDM8 (383), and S267F-pCDM8 (267) were subjected to HL immunopreclpitation and Western blot analysis as described in Fig 1 legend and "Methods." Lane 1 contains partially purified HLfrom human postheparin plasma (hHL); lanes 3 and 4, 5 and 6, and 7 and 8 represent HL immunoprecipitated from 2 mL media from two separate plates of wtHL, T383M, and S267F transfectants, respectively. Corresponding total HL activity from these 2-mL aliquots was 5.7 and 6.2 mU (wt, lanes 3 and 4), 0.48 and 0.30 mU (T383M, lanes 5 and 6), and 0.02 and 0.03 mU (S267F, lanes 7 and 8).
Fig 1 indicates that the mutant constructs expressed similar amounts of intracellular HL protein when compared with wtHL levels, although activity levels were significantly reduced (T383M) or absent (S267F) (see the Table and Fig 1 legend) . Thus, these mutations result in the presence of substantial amounts of HLinactive mass and do not appear to decrease protein stability. However, the molecular weight of both wtHL and mutant HL proteins was decreased from 57 000 to 55 000 D. This apparent reduction is most likely due to HL bearing high-mannose glycan chains; eg, the highmannose form of HL in rat liver has been shown to have an increased migration rate when compared with the mature form containing fully processed, complex sugar residues. 29 Because endo H is specific for high-mannose glycoproteins only, 30 digestion with this enzyme was used to confirm that intracellular HL possessed glycan chains of this structure. Indeed, both wtHL and mutant HL proteins treated with endo H decreased in size from 55 000 to 53 000 D (lanes 6 through 8), indicating removal of glycan chains of the high-mannose type.
Although S267F and T383M proteins were expressed at comparable levels intracellularly, secretion was substantially reduced compared with wtHL (Fig 2) . The relative amounts of secreted HL protein were determined by scanning densitometry and indicated that the S267F and T383M mutant proteins were present at only 12% and 20% of wild-type levels, respectively (average of two determinations on two separate samples). Nevertheless, this amount of secreted protein was appreciably higher than can be accounted for by the extracellular level of lipolytic activity, which was absent (S267F) or was only 4% of wild-type levels (T383M) (Table) . The comigration of the wtHL and mutant HL proteins (lanes 3 through 8) with HL isolated from human postheparin plasma (lane 1) indicates that the secreted forms were fully processed. Thus, S267F and T383M do not appear to gain any enzyme activity resulting from further oligosaccharide processing or secretion.
Discussion
Four families with heritable HL deficiency have been reported. 14 Affected individuals in two of these families were heterozygous for two missense mutations within the HL structural gene and one silent mutation (a G-»T change at nucleotide 522). 1415 The first missense mutation to be identified, designated T383M, was described as being "required but not sufficient" for expression of complete HL deficiency.
14 A second missense mutation, S267F, was subsequently identified and also shown to be associated with HL deficiency in one affected family. 15 Thus, although heterozygous individuals with either of these mutations exhibited reduced HL activity, the absence of detectable HL activity was apparent only in those individuals carrying both mutant alleles (T383M/S267F compound heterozygotes).
In this study, the etiologic nature of the T383M and S267F mutations in HL deficiency was tested by introducing these specific changes in the human HL cDNA and expressing the resultant constructs in COS cells. In this way, the effect of each mutation on HL activity and secretion could be examined independently, without the influence of a second allele or interference from other genetic factors. From our data, it is clear that both S267F and T383M mutations result in defective proteins that are poorly secreted, indicating that these mutations represent an underlying molecular defect in familial HL deficiency.
The S267F mutation abolished intracellular and extracellular HL activity and caused nearly a 90% reduction in secreted HL mass. Ser 267 , although not the acyl-accepting serine residue within the catalytic site, is nonetheless highly conserved, being found in all members of the lipase gene family in all species. 31 Faustinella et al 32 demonstrated that mutagenesis of this serine to alanine in lipoprotein lipase resulted in a protein that was expressed but had greatly reduced activity. Indeed, Ser 267 is adjacent to the a-helical "flap" region (or lid domain) present in all lipases, which is presumably responsible for lipase interfacial activation 33 and is only 10 residues away from the histidine residue contributing to the serine-histidine-aspartate catalytic triad. 31 Thus, it is not surprising that the S267F mutation, representing a nonconservative replacement of Ser^7 with the hydrophobic amino acid phenylalanine, has a profound effect on enzyme structure and function.
However, an unexpected and intriguing finding was the appreciable level of lipolytic activity within the cell lysates of T383M transfectants (38%), particularly when compared with the small fraction of activity secreted (4%) ( Table) . Why was not more of the intracellular activity secreted to the medium? The answer may depend on the nature of the T383M mutation with regard to its effect on the three-dimensional structure of the enzyme. One possibility for the observed reduction of HL activity is that a fraction (38%) of HL molecules carrying the T383M mutation can somehow still attain a normal or near-normal three-dimensional structure (expressing full enzyme activity) while the majority remain inactive, presumably as misfolded proteins. If this were the case, that fraction (38%) of structurally intact HL molecules with normal enzyme activity should be secreted; other studies have shown that protein folding is both a required and sufficient condition for secretion. 34 - 35 In fact, this is not observed: 4%, not 38%, of wild-type activity levels are present in the media.
A second possibility is that all HL T383M molecules are active but with a reduced enzyme-specific activity that is only 38% of wtHL. The T383M mutation may structurally alter this domain, resulting in decreased substrate recognition and lowered specific activity of all HL molecules. Thr 383 , although not conserved in either lipoprotein lipase or pancreatic lipase, 31 resides in the C-terminal domain of HL, a region important in substrate recognition, lipolysis, and heparin binding. 36 - 37 Because the T383M mutation also resulted in reduced secretion (Fig 2) , the structurally altered C-terminal domain may be recognized by the qualitycontrol mechanisms operating within the endoplasmic reticulum, resulting in its intracellular retention. 34 3s " 41 In conclusion, this study firmly establishes the importance of the T383M and S267F mutations in familial HL deficiency. These two mutations, however, appear to disrupt HL function differentially. The S267F mutation appears to result in a severely misfolded protein that is unable to function in any capacity. In contrast, the T383M mutation may affect only one region of the molecule -the C-terminal, or substrate recognition, domain-that permits the production of HL molecules with at least partial activity.
